Association between epidermal growth factor +61 G/A polymorphism and glioma risk in a chinese han population

Journal of International Medical Research

Volumn 38, Issue 5, 2010, Pages 1645-1652

  Bao, G ^a   Wang, M ^a   Guo, S ^a   Han, Y ^a   Xu, G ^a  

^a THE FIRST AFFILIATED HOSPITAL OF XI AN JIAOTONG UNIVERSITY   (China)

Author keywords

Chinese han population; Epidermal growth factor; Gene polymorphism; Gloma

Indexed keywords

ADENOSINE; EPIDERMAL GROWTH FACTOR; GUANIDINE;

ADULT; ARTICLE; ASTROCYTOMA; BLOOD ANALYSIS; BLOOD SAMPLING; CANCER GRADING; CANCER RISK; CHINESE; CONTROLLED STUDY; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; GLIOBLASTOMA; GLIOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; POPULATION RESEARCH; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT;

EID: 78449310596     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323001003800509     Document Type: Article

References (41)

1. Yan H, Parsons DW, Jin G, et al: IDH1 and IDH2 mutations in gliomas. N Engl J Med 2009; 360: 765-773.
2. Thurnher MM: 2007 World Health Organization classification of tumours of the central nervous system. Cancer Imaging 2009; 9(Spec No A): S1-S3.
3. Fuller GN, Scheithauer BW: The 2007 Revised World Health Organization (WHO) Classification of Tumours of the Central Nervous System: newly codified entities. Brain Pathol 2007; 17: 304-307.
4. Zhou XD, Wang XY, Qu FJ, et al: Detection of cancer stem cells from the C6 glioma cell line. J Int Med Res 2009; 37: 503-510.
5. Wang J, Liu X, Hou WH, et al: The relationship between intra-operative ultrasonography and pathological grade in cerebral glioma. J Int Med Res 2008; 36: 1426-1434.
6. Wen PY, Kesari S: Malignant gliomas in adults. N Engl J Med 2008; 359: 492-507.
7. Stupp R, Mason WP, van den Bent MJ, et al: Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005; 352: 987-996.
8. Tsitlakidis A, Foroglou N, Venetis CA, et al: Biopsy versus resection in the management of malignant gliomas: a systematic review and meta-analysis. J Neurosurg 2010; 112: 1020-1032.
9. Salomon DS, Brandt R, Ciardiello F, et al: Epidermal growth factor-related peptides and their receptors in human malignancies. Crit Rev Oncol Hematol 1995; 19: 183-232.
10. Cohen S: Isolation of a mouse submaxillary gland protein accelerating incisor eruption and eyelid opening in the new-born animal. J Biol Chem 1962; 237: 1555-1562.
11. Morton CC, Byers MG, Nakai H, et al: Human genes for insulin-like growth factors I and II and epidermal growth factor are located on 12q22-q24.1, 11p15, and 4q25-q27, respectively. Cytogenet Cell Genet 1986; 41: 245-249.
12. Shahbazi M, Pravica V, Nasreen N, et al: Association between functional polymorphism in EGF gene and malignant melanoma. Lancet 2002; 359: 397-401.
13. Jin G, Miao R, Deng Y, et al: Variant genotypes and haplotypes of the epidermal growth factor gene promoter are associated with a decreased risk of gastric cancer in a high-risk Chinese population. Cancer Sci 2007; 98: 864-868.
14. Zhang YM, Cao C, Liang K: Genetic polymorphism of epidermal growth factor 61A>G and cancer risk: a meta-analysis. Cancer Epidemiol 2010; 34: 150-156.
15. Lanuti M, Liu G, Goodwin JM, et al: A functional epidermal growth factor (EGF) polymorphism, EGF serum levels, and esophageal adenocarcinoma risk and outcome. Clin Cancer Res 2008; 14: 3216-3222.
16. Lim YJ, Kim JW, Song JY, et al: Epidermal growth factor gene polymorphism is different between schizophrenia and lung cancer patients in Korean population. Neurosci Lett 2005; 374: 157-160.
17. Kang HG, Choi JE, Lee WK, et al: +61A>G polymorphism in the EGF gene does not increase the risk of lung cancer. Respirology 2007; 12: 902-905.
18. Vishnoi M, Pandey SN, Modi DR, et al: Genetic susceptibility of epidermal growth factor +61A>G and transforming growth factor β1-509C>T gene polymorphisms with gallbladder cancer. Hum Immunol 2008; 69: 360-367.
19. Spindler KL, Nielsen JN, Ornskov D, et al: Epidermal growth factor (EGF) A61G polymorphism and EGF gene expression in normal colon tissue from patients with colorectal cancer. Acta Oncol 2007; 46: 1113-1117.
20. Kang S, Kim JW, Park NH, et al: Epidermal growth factor 61 A/G polymorphism and uterine cervical cancer. Int J Gynecol Cancer 2007; 17: 492-496.
21. Bhowmick DA, Zhuang Z, Wait SD, et al: A functional polymorphism in the EGF gene is found with increased frequency in glioblastoma multiforme patients and is associated with more aggressive disease. Cancer Res 2004; 64: 1220-1223.
22. Costa BM, Ferreira P, Costa S, et al: Association between functional EGF+61 polymorphism and glioma risk. Clin Cancer Res 2007; 13: 2621-2626.
23. Vauleon E, Auger N, Benouaich-Amiel A, et al: The 61 A/G EGF polymorphism is functional but is neither a prognostic marker nor a risk factor for glioblastoma. Cancer Genet Cytogenet 2007; 172: 33-37.
24. Liu X, Li L, Chen X, et al: No association between EGF +61 A/G polymorphism and increased risk of glioma. Int J Biol Markers 2009; 24: 77-82.
25. Pinto GR, Yoshioka FK, Clara CA, et al: Association study of an epidermal growth factor gene functional polymorphism with the risk and prognosis of gliomas in Brazil. Int J Biol Markers 2009; 24: 277-281.
26. Wang S, Zhao Y, Ruan Z, et al: Association between EGF +61 G/A and glioma risk in a Chinese population. BMC Cancer 2010; 10: 221.
27. Tanabe KK, Lemoine A, Finkelstein DM, et al: Epidermal growth factor gene functional polymorphism and the risk of hepatocellular carcinoma in patients with cirrhosis. JAMA 2008; 299: 53-60.
28. Pastore S, Mascia F, Mariani V, et al: The epidermal growth factor receptor system in skin repair and inflammation. J Invest Dermatol 2008; 128: 1365-1374.
29. Yarden Y, Shilo BZ: SnapShot: EGFR signaling pathway. Cell 2007; 131: 1018.
30. Zhang Z, Kimura M, Itokawa Y: The decrement of carcinogenesis by dietary selenium and expression of placental form of glutathione-S-transferase in rat glioma. Biol Trace Elem Res 1997; 57: 147-155.
31. Janik P, Szaniawska B, Kowalczyk D, et al: The effect of phorbol ester treatment on migration of C3H 10T1/2 and BT5C glioma cells: possible application to carcinogenesis. J Cancer Res Clin Oncol 1994; 120: 156-158.
32. Rooney AG, van Nieuwenhuizen D, Reijneveld JC, et al: Female gender is not a proven risk factor for depression in glioma. J Neurooncol 2009; 95: 449.
33. Houben MP, Louwman WJ, Tijssen CC, et al: Hypertension as a risk factor for glioma? Evidence from a population-based study of comorbidity in glioma patients. Ann Oncol 2004; 15: 1256-1260.
34. Hocking B: Occupational exposure to ionizing and non-ionizing radiation and risk of glioma. Occup Med (Lond) 2008; 58: 148-149 author reply 149.
35. Karipidis KK, Benke G, Sim MR, et al: Occupational exposure to ionizing and non-ionizing radiation and risk of glioma. Occup Med (Lond) 2007; 57: 518-524.
36. Ron E, Modan B, Boice JD, et al: Tumors of the brain and nervous system after radiotherapy in childhood. N Engl J Med 1988; 319: 1033-1039.
37. Holick CN, Giovannucci EL, Rosner B, et al: Prospective study of cigarette smoking and adult glioma: dosage, duration, and latency. Neuro Oncol 2007; 9: 326-334.
38. Silvera SA, Miller AB, Rohan TE: Cigarette smoking and risk of glioma: a prospective cohort study. Int J Cancer 2006; 118: 1848-1851.
39. Zheng T, Cantor KP, Zhang Y, et al: Risk of brain glioma not associated with cigarette smoking or use of other tobacco products in Iowa. Cancer Epidemiol Biomarkers Prev 2001; 10: 413-414.
40. Hurley SF, McNeil JJ, Donnan GA, et al: Tobacco smoking and alcohol consumption as risk factors for glioma: a case-control study in Melbourne, Australia. J Epidemiol Community Health 1996; 50: 442-446.
41. Efird JT, Friedman GD, Sidney S, et al: The risk for malignant primary adult-onset glioma in a large, multiethnic, managed-care cohort: cigarette smoking and other lifestyle behaviors. J Neurooncol 2004; 68: 57-69.